IMMP
Immutep Sp ADR (IMMP)
NASDAQ
$0.40-$0.01 (-3.61%)
Price as of Jun 03, 2026 8:00 PM EDT
  • $64.7M
    Market Cap
  • -77.57%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
10.3M
+31.80%
7.8M
+50.74%
5.2M
-23.05%
6.8M
+70.31%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
10.3M
+31.80%
7.8M
+50.74%
5.2M
-23.05%
6.8M
+70.31%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-49.8M
+58.17%
-31.5M
+9.30%
-28.8M
+13.64%
-25.3M
+110.78%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
8.6M
-2.35%
8.9M
+1.99%
8.7M
+20.38%
7.2M
+14.77%
Operating Profit
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-61.4M
+43.82%
-42.7M
+7.07%
-39.9M
+23.86%
-32.2M
+7.72%
Income Taxes
0
N/A
0
N/A
0
-100.00%
34
+3.03%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-61.4M
+43.82%
-42.7M
+7.07%
-39.9M
+23.86%
-32.2M
+7.72%
Net Income from Continuing Operations Applicable to Common
-61.4M
+43.82%
-42.7M
+7.07%
-39.9M
+23.86%
-32.2M
+7.72%
Basic EPS and Net Income
-0.04
+18.54%
-0.04
-20.36%
-0.04
+17.94%
-0.04
-99.25%
Diluted EPS and Net Income
-0.04
+18.54%
-0.04
-20.36%
-0.04
+17.94%
-0.04
-99.25%
Basic Weighted Average Shares
1.5B
+21.21%
1.2B
+34.59%
892.4M
+5.12%
849.0M
+42.70%
Diluted Weighted Average Shares
1.5B
+21.21%
1.2B
+34.59%
892.4M
+5.12%
849.0M
+42.70%
Balance Sheet
Cash and Cash Equivalents
67.4M
-58.34%
161.8M
+31.09%
123.4M
+54.28%
80.0M
+32.02%
Short-Term Investments
12.5M
-37.77%
20.1M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
79.9M
-56.06%
181.9M
+47.37%
123.4M
+54.28%
80.0M
+32.02%
Total Current Assets
149.1M
-22.08%
191.4M
+41.78%
135.0M
+48.62%
90.8M
+32.73%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
63,458
+0.50%
63,145
-24.05%
83,144
+119.19%
37,933
-7.23%
Total Long-Term Assets
7.9M
-22.90%
10.2M
-18.06%
12.5M
+9.91%
11.4M
-16.56%
Total Assets
157.0M
-22.12%
201.6M
+36.71%
147.4M
+44.32%
102.2M
+24.55%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
12.8M
+21.67%
10.5M
+7.31%
9.8M
+52.34%
6.4M
+20.12%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
589,227
-62.50%
1.6M
+30.12%
1.2M
-28.03%
1.7M
-50.93%
Total Liabilities
13.3M
+10.70%
12.1M
+9.82%
11.0M
+35.68%
8.1M
-7.61%
Retained Earnings
-444.1M
+16.06%
-382.6M
+12.57%
-339.9M
+12.43%
-302.3M
+10.08%
Total Stockholders Equity
143.6M
-24.21%
189.5M
+38.87%
136.5M
+45.06%
94.1M
+28.40%
Total Shares Outstanding
1.5B
+0.54%
1.5B
+22.35%
1.2B
+37.06%
866.2M
+15.78%
Cash Flow
Cash from Operating Activities
-62.0M
+78.20%
-34.8M
-1.51%
-35.4M
+16.96%
-30.2M
+71.37%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-38.5M
+83.33%
-21.0M
+25,304.82%
-82,735
+261.07%
-22,914
+46.88%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-525,121
-100.55%
95.2M
+25.20%
76.0M
+51.06%
50.3M
-4.47%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-34.27%
+39.99%
-24.48%
-23.43%
-31.97%
-8.60%
-34.97%
-24.78%
Return on Equity
-36.88%
+40.72%
-26.21%
-24.28%
-34.61%
-10.09%
-38.50%
-31.40%
Revenue Growth
31.80%
-37.32%
50.74%
+320.10%
-23.05%
-132.79%
70.31%
+192.57%
Current Ratio
11.69
-35.96%
18.25
+32.12%
13.81
-2.44%
14.16
+10.50%
Cash Ratio
5.28
-65.76%
15.43
+22.16%
12.63
+1.27%
12.47
+9.91%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow